First-line cabozantinib declined for a second time for use within NHS Scotland
Cabozantinib has been declined for a second time by the [...]
Cabozantinib has been declined for a second time by the [...]
Using gene profiling, a recent study published in Cancer Discovery [...]
A recent study, published in The Lancet Public Health, has [...]
A Swedish biotechnology company, Elypta, has recently been awarded an [...]
Results from a phase 2 study to assess the activity [...]
A recent study reports the real-world safety and efficacy of [...]
Today (4th February) is World Cancer Day, and KCSN are [...]